S&P 500 stocks have been outperforming their smaller peers in the Russell 2000 the last four years.

Transcript

00:00 Over the last 3 and 1/2 years, the S&P 500 has vastly outperformed the Russell 2000 to the tune of about 70%.

00:09 But can this outperformance of large cap stocks last in our small cap stocks a bargain?

00:20 Well, the truth is, over a very long period of time, both large cap stocks and small cap stocks tend to generate about the same performance, but they tend to do it at different times.

00:32 The large cap stocks of the S&P 500 tend to outperform during the later stages of economic recoveries, like during the late 1980s, the late 1990s, and after the year 2013, up until the pandemic of 2020.

00:48 By contrast, small cap stocks tend to do better at the beginnings of economic expansions, and also during recessions.

00:55 So if the economy experiences a downturn, the Russell 2000 could be a massive outperformer.

01:01 But here's one other reason to think that might be the case.

01:04 Look at the relative differences in their valuation ratios.

01:08 The S&P 500 trades at three times sales.

01:12 The Russell 2000, only one time sales.  

01:15 When it comes to book value, The S&P 500 is trading at five times book, compared to only two times to the Russell 2000.

01:22 So small cap stocks are looking like a bargain.

01:25 The question is, will they begin to outperform?


The information herein has been complied by CME Group for general informational and education purposes only and does not constitute trading advice or the solicitation of purchases or sale of futures, options, swaps, any other financial instrument, or financial service. The views in this video reflect solely those of the author or speaker and not necessarily those of CME Group or its affiliated institutions. All examples discussed are hypothetical situations, used for explanation purposes only, and should not be considered investment advice of the results of actual market experience. Although every attempt has been made to ensure the accuracy of the information herein, CME Group and its affiliates assume no responsibility for any errors or omissions. All data is sourced by CME Group unless otherwise stated. All matters pertaining to rules and specification herein are made subject to and are superseded by applicable CME Group rules. Current rules should be consulted in all cases concerning contract specifications.

CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and, E-mini are trademarks of Chicago Mercantile Exchange Inc.  CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc.  NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc.  COMEX is a trademark of Commodity Exchange, Inc. BrokerTec and EBS are trademarks of BrokerTec Europe LTD and EBS Group LTD, respectively.   All other trademarks are the property of their respective owners.   

Neither futures trading nor swaps trading are suitable for all investors, and each involves the risk of loss. Swaps trading should only be undertaken by investors who are Eligible Contract Participants (ECPs) within the meaning of Section 1a(18) of the Commodity Exchange Act. Futures and swaps each are leveraged investments and, because only a percentage of a contract’s value is required to trade, it is possible to lose more than the amount of money deposited for either a futures or swaps position. Therefore, traders should only use funds that they can afford to lose without affecting their lifestyles and only a portion of those funds should be devoted to any one trade because traders cannot expect to profit on every trade.

Please click here for CME Group’s full disclaimer.

CME Group is the world’s leading derivatives marketplace. The company is comprised of four Designated Contract Markets (DCMs). 
Further information on each exchange's rules and product listings can be found by clicking on the links to CME, CBOT, NYMEX and COMEX.

© 2025 CME Group Inc. All rights reserved.